Progress in the Management of Bone Metastases: One Continent at a Time?
- 20 May 2005
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (15) , 3299-3301
- https://doi.org/10.1200/jco.2005.11.931
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Zoledronic Acid Significantly Reduces Skeletal Complications Compared With Placebo in Japanese Women With Bone Metastases From Breast Cancer: A Randomized, Placebo-Controlled TrialJournal of Clinical Oncology, 2005
- Zoledronic AcidDrugs, 2004
- Metastatic bone disease: clinical features, pathophysiology and treatment strategiesCancer Treatment Reviews, 2001
- Bisphosphonates: from the laboratory to the clinic and back againBone, 1999
- Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled TrialJournal of Clinical Oncology, 1999
- ClodronateDrugs & Aging, 1999
- Pharmacology and clinical efficacy of bisphosphonatesCurrent Opinion in Oncology, 1998
- Bisphosphonates and breast carcinomaCancer, 1997
- Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone MetastasesNew England Journal of Medicine, 1996
- Bone metastasis in breast cancerAnti-Cancer Drugs, 1992